AMBER YOUNG: Open Payments
NPI 1427331776 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 23 payments from 12 companies in 2025. Trend: 2023 $712 · 2024 $882 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $178 |
| GENZYME CORPORATION | 3 | $102 |
| ABBVIE INC. | 4 | $84 |
| LEO Pharma Inc. | 2 | $58 |
| Incyte Corporation | 2 | $54 |
| Galderma Laboratories, L.P. | 1 | $49 |
| Janssen Biotech, Inc. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
Products named: DUPIXENT, EBGLYSS, ANZUPGO, TALTZ, OPZELURA, BOTOX, TREMFYA, Rhapsido.
Industry payments across CA — which companies pay providers there.
